ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is a myeloproliferative disease characterized by the presence of the Philadelphia chromosome, involving a translocation between chromosomes 9 and 22 producing the bcr-abl fusion protein and exhibiting constitutive tyrosine kinase signaling activity.